Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer: Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. J Clin Oncol 2004;22:2532–9

✍ Scribed by Gurkamal Chatta

• Book ID: 116955675
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 43 KB
• Volume: 22
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2004.09.003